Clinical Trials Logo

Lymphedema of Upper Limb clinical trials

View clinical trials related to Lymphedema of Upper Limb.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06036173 Completed - Clinical trials for Lymphedema of Upper Limb

Body Awareness and Functionality in Lymphedema

Start date: August 16, 2023
Phase:
Study type: Observational

To determine whether body awareness and upper extremity functionality are affected in patients with or without lymphedema development after breast cancer surgery in comparison with individuals without a history of cancer.

NCT ID: NCT05754346 Completed - Clinical trials for Lymphedema of Upper Limb

Does Inclusion of Diaphragmatic Breathing Exercises in Complete Decongestive Therapy Provide Further Benefits in Patients With Breast Cancer Related Lymphedema

Start date: March 20, 2023
Phase: N/A
Study type: Interventional

Complete decongestive therapy is proven to be effective in reducing lymphedema related symptoms such as swelling and pain. Breathing exercises, on the other hand, may also help managing lymphedema symptoms. Deep breathing creates a pressure change in the abdomen, which creates a vacuum effect in the thoracic cavity and helps to empty the lymphatic vessels. Thus, we aimed to investigate whether addition of diaphragmatic breathing exercises to physical exercise component of complete decongestive therapy provides further benefits on lymphedema volume, pain and quality of life in patients with breast cancer related lymphedema.

NCT ID: NCT05660590 Completed - Clinical trials for Breast Cancer Lymphedema

Effect of Different Bandage Interface Pressures on Breast Cancer Related Lymphedema

BCRL
Start date: June 1, 2019
Phase: N/A
Study type: Interventional

The goal of this randomised comparison study is to compare different bandage interface pressures in individuals with breast cancer related lymphedema The main questions it aims to answer are: - Is high or low bandage pressure effective in reducing edema and soft tissue thickness? - do bandages applied with high or low bandage pressure comprimise sleep, comfort or subjective benefit from treatment? Participants will recieve complex decongestive physiotherapy. Bandage will apply high or low pressure. Effects of high and low bandage interface pressures will compare

NCT ID: NCT05037708 Completed - Clinical trials for Lymphedema of Upper Limb

Effects of Physiotherapy in the Treatment of Lymphedema After Breast Cancer

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Lymphedema related to breast cancer is one of the main complications after breast cancer treatment. Manual lymphatic drainage appears as a technique which could be applied in the treatment of lymphedema along with other techniques. The aim of this study is to analyze the effects of a physiotherapy program based on manual lymphatic drainage on the treatment of lymphedema after breast cancer, during the stabilization or maintenance phase of complex decongestant therapy. Therefore, a randomized, blinded, crossover clinical trial is suggested to assess the effect of an intensive physiotherapy intervention on the treatment of lymphedema in its maintenance phase, in comparison with a control group without physiotherapy treatment. The cytometry, displaced water volume, thickness of the lymphedema with ultrasound, dynamometry and sensation of heaviness, pain and tension of the upper limb will be evaluated.

NCT ID: NCT04766489 Completed - Breast Cancer Clinical Trials

Evaluation of the Treatment Response in Breast Cancer Related Lymphedema

Start date: July 11, 2019
Phase: N/A
Study type: Interventional

This study aims to evaluate the effects of the treatment for breast cancer lymphedema. After taking a detailed history and giving a physical examination, breast cancer related lymphedema patients(n:30) will be informed and will be given Complete Decongestive Therapy, which includes decongestive exercises, manual lymphatic drainage, compression therapy(either through short stretch bandaging and/or pneumatic device) and exercise. Patients will be evaluated with limb volume, lymphedema index acquired through bioimpedance device, QuickDASH for upper extremity function, hand dynamometer for upper extremity grip strength and CLUE(Breast Cancer-Related Lymphedema of the Upper Extremity standardized clinical evaluation tool) scoring for lymphedema before and after the intervention. The values will be compared in order to show whether there are significant differences between before and after scores, and whether CLUE score is correlated with the other indicators of breast cancer related lymphedema.

NCT ID: NCT04575636 Completed - Clinical trials for Lymphedema of Upper Limb

MRL in the Upper Extremity

Start date: September 10, 2020
Phase: N/A
Study type: Interventional

Objective: The aim of this study is to examine the feasibility and applicability of the MRL protocol for the upper extremity in Maastricht University Medical Center, and to examine the differences of the lymphatic system between lymphedema patients and healthy volunteers. Study design: An explorative study of an MRL protocol for the upper extremity in Maastricht University Medical Center+. Study population: There are two study groups. The first group (n=10) consists of patients with secondary lymphedema in the upper extremity. The second group (n=10) consists of healthy volunteers. Intervention (if applicable): All participants will undergo an MRL examination with the same protocol, developed in a previous 'proof of principle' study, in the Maastricht University Medical Center+. After localizer scans, a T2-weighted sequence is used. Then a T1-weighted sequence will be made before the injection of contrast. After the injection of the contrast agent a T1-weighted sequences of the upper and lower arm are performed alternately. Main study parameters/endpoints: The primary outcome is to determine the feasibility and applicability of the MRL protocol by evaluating the images of the upper extremity in patients with secondary lymphedema and healthy subjects. The secondary outcome is to assess the value of MRL in staging lymphedema.

NCT ID: NCT03252145 Completed - Clinical trials for Lymphedema of Upper Limb

Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device

Start date: October 31, 2017
Phase: N/A
Study type: Interventional

This study will be a 4 to 6 week randomized, controlled, assessor blinded, trial comparing a negative pressure massage device (intervention group), to the standard manual lymph drainage massage (control group), in breast cancer patients with chronic upper extremity lymphedema.